These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 27918194)

  • 1. First report of tumor treating fields use in combination with bevacizumab in a pediatric patient: a case report.
    O'Connell D; Shen V; Loudon W; Bota DA
    CNS Oncol; 2017 Jan; 6(1):11-18. PubMed ID: 27918194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case of glioblastoma patient treated with tumor treating fields therapy at recurrence degenerating to sarcoma.
    Majd P; O'Connell DE; Kim RC; Bota DA; Carrillo JA
    CNS Oncol; 2017 Apr; 6(2):89-94. PubMed ID: 28303729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor treating fields: a novel and effective therapy for glioblastoma: mechanism, efficacy, safety and future perspectives.
    Zhu P; Zhu JJ
    Chin Clin Oncol; 2017 Aug; 6(4):41. PubMed ID: 28841803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor treating field therapy in combination with bevacizumab for the treatment of recurrent glioblastoma.
    Omar AI
    J Vis Exp; 2014 Oct; (92):e51638. PubMed ID: 25407354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nivolumab for patients with recurrent glioblastoma progressing on bevacizumab: a retrospective case series.
    Chamberlain MC; Kim BT
    J Neurooncol; 2017 Jul; 133(3):561-569. PubMed ID: 28500559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cs-131 brachytherapy for patients with recurrent glioblastoma combined with bevacizumab avoids radiation necrosis while maintaining local control.
    Wernicke AG; Taube S; Smith AW; Herskovic A; Parashar B; Schwartz TH
    Brachytherapy; 2020; 19(5):705-712. PubMed ID: 32928486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of tumor treating fields for newly diagnosed glioblastoma: understanding of nationwide practice patterns.
    McClelland S; Sosanya O; Mitin T; Degnin C; Chen Y; Attia A; Suh JH; Jaboin JJ
    J Neurooncol; 2018 Oct; 140(1):155-158. PubMed ID: 29987746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Safety of Bevacizumab Administered Shortly after Laser Interstitial Thermal Therapy in Glioblastoma: A Case Series.
    Ali SC; Basil GW; Diaz RJ; Komotar RJ
    World Neurosurg; 2018 Sep; 117():e588-e594. PubMed ID: 29933086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of glioblastoma: State of the art and future directions.
    Tan AC; Ashley DM; López GY; Malinzak M; Friedman HS; Khasraw M
    CA Cancer J Clin; 2020 Jul; 70(4):299-312. PubMed ID: 32478924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bevacizumab and radiotherapy for the treatment of glioblastoma: brothers in arms or unholy alliance?
    Niyazi M; Harter PN; Hattingen E; Rottler M; von Baumgarten L; Proescholdt M; Belka C; Lauber K; Mittelbronn M
    Oncotarget; 2016 Jan; 7(3):2313-28. PubMed ID: 26575171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
    Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
    J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor treating fields in pediatric high-grade glioma.
    Green AL; Mulcahy Levy JM; Vibhakar R; Hemenway M; Madden J; Foreman N; Dorris K
    Childs Nerv Syst; 2017 Jul; 33(7):1043-1045. PubMed ID: 28470383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of concurrent radiation therapy, temozolomide, and bevacizumab followed by bevacizumab/everolimus as first-line treatment for patients with glioblastoma.
    Hainsworth JD; Shih KC; Shepard GC; Tillinghast GW; Brinker BT; Spigel DR
    Clin Adv Hematol Oncol; 2012 Apr; 10(4):240-6. PubMed ID: 22706484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A state-of-the-art review and guidelines for tumor treating fields treatment planning and patient follow-up in glioblastoma.
    Trusheim J; Dunbar E; Battiste J; Iwamoto F; Mohile N; Damek D; Bota DA; Connelly J
    CNS Oncol; 2017 Jan; 6(1):29-43. PubMed ID: 27628854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADC quantification to classify patients candidate to receive bevacizumab treatment for recurrent glioblastoma.
    Asenjo García B; Navarro Guirado F; Nagib Raya F; Vidal Denis M; Bravo Rodríguez F; Galán Montenegro P
    Acta Radiol; 2020 Mar; 61(3):404-413. PubMed ID: 31357873
    [No Abstract]   [Full Text] [Related]  

  • 16. Alternating electric tumor treating fields for treatment of glioblastoma: rationale, preclinical, and clinical studies.
    Mittal S; Klinger NV; Michelhaugh SK; Barger GR; Pannullo SC; Juhász C
    J Neurosurg; 2018 Feb; 128(2):414-421. PubMed ID: 28298023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Notch expression in glioma stem cells on therapeutic response to chemo-radiotherapy in recurrent glioblastoma.
    Saito N; Aoki K; Hirai N; Fujita S; Iwama J; Hiramoto Y; Ishii M; Sato K; Nakayama H; Harashina J; Hayashi M; Izukura H; Kimura H; Ito K; Sakurai T; Yokouchi Y; Oharazeki T; Takahashi K; Iwabuchi S
    Brain Tumor Pathol; 2015 Jul; 32(3):176-83. PubMed ID: 25665548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II study of panobinostat in combination with bevacizumab for recurrent glioblastoma and anaplastic glioma.
    Lee EQ; Reardon DA; Schiff D; Drappatz J; Muzikansky A; Grimm SA; Norden AD; Nayak L; Beroukhim R; Rinne ML; Chi AS; Batchelor TT; Hempfling K; McCluskey C; Smith KH; Gaffey SC; Wrigley B; Ligon KL; Raizer JJ; Wen PY
    Neuro Oncol; 2015 Jun; 17(6):862-7. PubMed ID: 25572329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bevacizumab-Related Hyperintense Lesions on Diffusion-Weighted Imaging at Different Locations in a Patient with Malignant Glioma].
    Oshiro S; Wakuta N; Kawai S; Miki K; Shigemori Y
    No Shinkei Geka; 2017 Jun; 45(6):509-517. PubMed ID: 28634311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AVAglio: Phase 3 trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma multiforme.
    Chinot OL; de La Motte Rouge T; Moore N; Zeaiter A; Das A; Phillips H; Modrusan Z; Cloughesy T
    Adv Ther; 2011 Apr; 28(4):334-40. PubMed ID: 21432029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.